| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |